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ABSTRACT 
Objective- The outstanding  position of piperidine analogues  has proven them an important core in the structures of pharmaceutically active 
molecules, naturally occurring alkaloids, pharmaceuticals and as synthetic intermediates with interesting biological, physical and pharmacological 
behaviors. The  piperidine ring containing compound like pethidine having strong opiod analgesic activity, more potent than codein and controls the 
pain of smooth muscle spasm. Because of having similarity in structure the present study was aimed to estimate the analgesic activity of synthesized 
derivatives of 4-(4′-Chlorophenyl)-4-hydroxy piperidine.  
Method- The present study was conducted in animal model, mice by using Pethidine as standard drug. For which the Eddy’s hot plate method was 
adopted and analgesia ( mean increase in latency)  was observed.  
Result- The result showed the more prominent response of substituted compound than the parent one “4-(4′-Chlorophenyl)-4-hydroxy piperidine” 
and it was studied that alteration in the molecule structure is accountable for  a better analgesic response. 
Conclusion- The studies proved the positive pharmacological responsiveness of the combination of 4-(4′-Chlorophenyl)-4-hydroxy piperidine with 
phencyl halides. These synthesized derivatives will establish as potent analgesics. 
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INTRODUCTION 
The analgesic activity engages a multifarious communication of 
nervous system from the skin and the muscule tissues to the brain. 
The opioid receptors are responsible for producing  nociception and 
also causes antinociception effects. It is closely connected with all 
CNS areas. Hence the facts reveal that the analgesia and 
antinoceception are closely and strongly associated with binding of 
opiod receptor with a suitable psychoactive chemical, an opiate [1, 
2]. The credit that opioid therapy can reduce pain and improve 
functioning in many patients with chronic pain has directed drug 
experts to recommend opioids [3].  The piperidine ring containing 
compounds due to having similarity in the structure with morphine 
belongs to the same class of drug and cause analgesia by blocking 
the signaling pathways against pain as like Pethidine (Figure-1), 
Bemidone and Ketobemidone that are more effective analgesic 
compounds [4] because the substituted piperidine molecule 
exhibited potential therapeutic properties due to the structure 
activity relationship and good receptor binding and considered as 
leading nucleus used for the treatment pain and inflammation [5, 6]. 
There is a long series of piperidine derivatives which has proved 
potent antinociceptive agent. Among them Fentanyl (Figure-2), a 
synthetic opiod analgesic, was derivatized  from 1-Phenethyl-4-
piperidone, exhibited a better profile of activity as compare to 
morphine [7]. The substitution was studied on two different   
positions of piperidine ring. The structural activity relationship 
revealed that substitution on position 3 by the group larger than 
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Figure-1: Pethidine                                                                         








 Ohmefentanyl and Remifentanyl are extremely potent 
analgesic agents with highest receptor affinity and 
selectivity for the opioid µ receptors [9, 10].  
METHOD 
The analgesic activity of synthesized derivatives of 4-(4′-
Chlorophenyl)-4-hydroxy piperidine was conducted by Eddy’s hot 
plate method [11, 12]. These compounds were synthesized by 
reacting with different phenacyl halide according to the designed 
reaction scheme [13 ] For conducting the analgesic study albino 
mice of either sex. The weight of all the mice ranged from 20-30g 
that were divided in the groups of six each. The animals were 
provided standard colony conditions (12 hrs night and 12hrs dark) 
as proper diet and water before the administration of drugs and 
were kept at a temperature of 30 ± 1°C. The parent compound 4-4-
Chlorophenyl Piperidine  and derivatives were tested orally for 
analgesic effect at the effective dose of 50mg/ Kg weight (as 25mg/ 
Kg weight was found ineffective and 75mg/ Kg weight was observed 
lethal. Pethidine (5mg/Kg) and gum tragacanth were used as 
standard drug and vehicle respectively. The activity of compounds 
was assessed at a temperature of 55±1oC. The control groups 
received only the vehicle. Analgesic effects were observed at 30, 60, 
90, 120, and180 minutes after administration and six animals were 
taken in a group. The analgesia was measured by the writhings after 
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the administration of drugs (compounds) and the results were 
summarized in the form of analgesic activity (Tables: 1) that was 
expressed as analgesia, mean increase in latency after drug 
administration ± SEM and was calculated. Student’s t-test was 
applied for statistical analysis and P<0.05 or P<0.01 were 
considered as significant or highly significant values respectively. 
 RESULTS AND DISCUSSIONS 
Piperidine ring containing compounds are identified as potent 
analgesic. Consequently extensive research has been done for the 
substitution of piperidine to get better moiety for the management 
of pain. Structural modification can lead to achieve good quality 
analgesics having little side effects with potent pain controlling 
ability [14, 15]. Number of other piperidine derivatives having 
significant analgesic activity were synthesized by different workers 
and among them mostly substituted piperidine derivatives were 
experimentally proved strong   antinociceptive agent [16]. During 
the present study the synthsized molecules were analysed for the 
analgesic behaviour  (Table-1) by producing thermal pain stimuli 
[17] and it was observed that the  parent compound 4-(4′-
Chlorophenyl)-4-hydroxy piperdine showed negligible analgesic 
effect and hence it was considered as inactive and non significant 
analgesic. But Interestingly encouraging results were obtained by all 
the phenacyl derivatives of 4-(4′-Chlorophenyl)-4-Hydroxy 
piperdine proved active analgesic. As 1-(1′′-Adamantan acyl)-4-(4′-
chlorophenyl)-4-hydroxy piperidinium Hydrobromide (I), showed 
analgesic response highly significant level (p<0.01) after 30 minutes 
that remained till one hour and observed significant (p<0, 05) after 
90 and 120 minutes but response was shown inactive after 180 
minutes. Derivative 1-(6′′-Methyluracil)-4-(4′-chlorophenyl)-4-
hydroxy piperidinium Hydrochloride (III) also  proved an excellent  
 
analgesic by giving the  response of  highly significant level with 
more a quick onset immediately after 30 minutes that was observed 
highly significant till 180minutes. Derivative, 1-(1′′-Phenoxypropyl)-
4-(4′-chlorophenyl)-4-hydroxy piperidinim Hydrobromide (IV), 
exhibited strong analgesia of significant level (p<0.05) immediately 
after 30 minutes that was observed constant till two hours and after 
that the response become of  highly significant level. Derivative, 1-
(3′′-Phenylpropyl)-4-(4′-chlorophenyl)-4-hydroxy piperidinium 
hydrobromide (V), exhibited potent analgesic response of highly 
significant level (p<0.01) after one hour of drug administration that 
was observed constant till 180 minutes. The substitution of methyl 
group at the phenacyl nitrogen was responsible for a significant 
change in the antinoceceptive activity of piperidine. All the 
synthesized derivatives were belonging to opioid analgesics group. 
These investigations were conducted to study the structure-activity-
relationship (SAR) of the subsituent group on the nitrogen of 
piperidine derivatives. The results showed that the methyl group 
severely enhanced the analgesic potency. Whereas the duration of 
action usually did not depend on the methyl group substitution, 
prolonged action of the derivatives might due to the substitution of 
group in structure such as methoxy that may modify the duration of 
action by affecting the pharmacokinetic properties. SAR studies with 
refrence to analgesia suggested that the opiod receptors were 
responsible for antinociceptive, hence in the series of substituted 
piperidine analogues, the nature of receptor binding with the 
structure of whole molecule describes analgesic response and hence 
the strength and also the duration of action may be influenced only 
by the steric effect. In present study though all the synthesized 
piperidine were encouraging, whenevaluated for analgesia. 
Compounds having significant and highly significan results, can be 
selected for further studies regarding antinoceciptive activity.  
Table-1: Analgesic Effects of 4-(4′-Chlorophenyl)-4-Hydroxy Piperdine Derivatives 
Dose(Oral) 
50mg/Kg 
Analgesia (mean increase in latency after drug administration ± SEM) 
       Time  30min 60min 90min 120min 180min 
Control 0.53±0.53 0.8±0.55 1.04±0.53 1±0.53 0.9±0.53 
I( Parent)  0.09± 0.11 0.22±0.19 1.01±0.11 0.08± 0.06 0.13±0.50 
II(Derivative) 7.32**±7.29 6.32**±3.95 5.85**±5.00 4.82**±5.70 6.00**±2.29 
III (Derivative) 2.65**±5.93 3.83*±4.14 3.88**±4.14 4.43**±4.69 4.12**±3.24 
IV (Derivative) 0.42*±3.60 0.02*±4.95 0.18*±6.27 2.17*±3.52 3.72**±4.64 
V (Derivative) 0.13±4.28 4.55**±5.98 5.33**±6.45 2.70**±4.12 2.43**±4.55 
Pethidine HCl 2.26±0.63 3.52±0.46 2.82±0.13 2.57±0.23 1.57±0.2 
Activity Key:    Significant= *     Highly significant= ** 
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